Direct-Acting Antivirals Tied to Lower Risk of Liver Cancer in HCV

A new study found that direct-acting antiviral treatment is linked to decreased risk of liver cancer, liver-related death, and all-cause mortality.  

Source: ConsultantLive - March 7, 2019 Category: Internal Medicine Authors: Veronica Hackethal, MD Tags: Hepatitis C Source Type: news